Contact this trialFirst, we need to learn more about you.
CAR T-cell Therapy
CAR T Cells +/− Lenalidomide for Multiple Myeloma
Recruiting1 awardPhase 1
New York, New York
This trial is testing if CAR T cells are safe for patients with myeloma. In the first part of the study, they screen patients and collect cells. In the second part of the study, they treat patients with the CAR T cells.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.